Sonja Zweegman Selected Research

Zoledronic Acid (Zometa)

1/2021	Treatment of multiple myeloma-related bone disease: recommendations from the Bone Working Group of the International Myeloma Working Group.
10/2015	European Myeloma Network guidelines for the management of multiple myeloma-related complications.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sonja Zweegman Research Topics

Disease

91	Multiple Myeloma 02/2022 - 07/2005
28	Neoplasms (Cancer) 08/2022 - 11/2012
12	Leukemia 01/2021 - 10/2007
11	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 10/2010
7	Hematologic Neoplasms (Hematological Malignancy) 06/2022 - 10/2010
7	Primary Myelofibrosis (Myelosclerosis) 01/2022 - 11/2012
6	Infections 08/2022 - 05/2013
6	Disease Progression 12/2021 - 01/2014
5	Residual Neoplasm 11/2021 - 09/2005
5	Thrombocytopenia (Thrombopenia) 10/2019 - 10/2010
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2021 - 12/2013
4	Chromosome Aberrations (Chromosome Abnormalities) 01/2021 - 01/2016
3	Lymphoma (Lymphomas) 01/2022 - 04/2016
3	Frailty 01/2022 - 09/2017
3	Bone Diseases (Bone Disease) 01/2021 - 04/2012
3	Plasmacytoma 06/2020 - 01/2011
3	Amyloidosis 11/2019 - 05/2013
3	Essential Thrombocythemia 01/2016 - 11/2012
3	Renal Insufficiency (Renal Failure) 11/2014 - 01/2005
2	Neutropenia 08/2022 - 10/2021
2	Septic Shock (Toxic Shock Syndrome) 08/2022 - 10/2021
2	Fever (Fevers) 08/2022 - 01/2011
2	COVID-19 01/2022 - 01/2020
2	Testicular Neoplasms (Testicular Cancer) 01/2022 - 10/2010
2	Pain (Aches) 01/2021 - 12/2020
2	Inflammation (Inflammations) 12/2019 - 07/2005
2	Anemia 12/2017 - 10/2015
2	Hemorrhage 01/2017 - 01/2016
2	Thrombosis (Thrombus) 01/2017 - 01/2016
2	Splenomegaly 01/2016 - 08/2013
2	Venous Thrombosis (Deep-Vein Thrombosis) 01/2016 - 12/2002
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 02/2015 - 01/2014
2	Polycythemia Vera 07/2014 - 11/2012
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 06/2014 - 01/2013
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 05/2012 - 07/2002
2	alpha-Thalassemia 01/2007 - 01/2005
1	Febrile Neutropenia 08/2022
1	Pneumonia (Pneumonitis) 08/2022
1	Fever of Unknown Origin 08/2022
1	Respiratory Insufficiency (Respiratory Failure) 08/2022
1	Bronchiolitis Obliterans Syndrome 01/2022

Drug/Important Bio-Agent (IBA)

27	Bortezomib (Velcade)FDA Link 10/2021 - 07/2005
21	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 12/2006
19	Thalidomide (Thalomid)FDA Link 10/2021 - 01/2008
18	daratumumabIBA 01/2022 - 01/2016
17	Proteasome InhibitorsIBA 01/2021 - 01/2013
16	Lenalidomide (CC 5013)FDA Link 01/2022 - 04/2010
13	Melphalan (Alkeran)FDA LinkGeneric 01/2022 - 02/2010
12	Monoclonal AntibodiesIBA 11/2021 - 05/2013
10	AntigensIBA 01/2022 - 12/2002
8	Proteins (Proteins, Gene)FDA Link 11/2021 - 01/2007
8	ixazomibIBA 01/2021 - 09/2017
7	Chimeric Antigen ReceptorsIBA 01/2022 - 01/2017
7	carfilzomibIBA 08/2020 - 12/2013
7	Prednisone (Sone)FDA LinkGeneric 06/2020 - 07/2010
6	ruxolitinibIBA 01/2022 - 07/2017
6	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2021 - 12/2013
5	Pharmaceutical PreparationsIBA 08/2022 - 06/2013
5	fedratinibIBA 01/2022 - 07/2017
4	Immunoglobulin G (IgG)IBA 01/2022 - 06/2014
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 03/2014
4	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2014
4	Rituximab (Mabthera)FDA Link 01/2017 - 01/2013
3	pomalidomideIBA 02/2022 - 09/2017
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 02/2010
3	Immunomodulating AgentsIBA 01/2020 - 09/2017
3	Histone Deacetylase InhibitorsIBA 01/2018 - 07/2014
3	Syntex adjuvant formulationIBA 12/2017 - 11/2012
2	Biological ProductsIBA 01/2022 - 06/2014
2	Janus Kinase InhibitorsIBA 01/2022 - 01/2016
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 12/2021 - 01/2014
2	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 12/2021 - 11/2020
2	Bispecific AntibodiesIBA 10/2021 - 11/2020
2	Zoledronic Acid (Zometa)FDA Link 01/2021 - 10/2015
2	CytokinesIBA 01/2021 - 01/2017
2	EpitopesIBA 01/2021 - 01/2019
2	Complement System Proteins (Complement)IBA 12/2020 - 12/2017
2	Immunoglobulin A (IgA)IBA 11/2020 - 06/2014
2	AntibodiesIBA 04/2020 - 01/2018
2	ADP-ribosyl Cyclase 1IBA 01/2019 - 01/2017
2	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 11/2016
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2017 - 02/2015
2	Hemoglobins (Hemoglobin)IBA 10/2015 - 01/2007
2	Vorinostat FDA Link 07/2014 - 08/2013
2	PR-957IBA 01/2014 - 12/2013
2	L-SelectinIBA 06/2007 - 07/2005
1	Meropenem (Merrem)FDA LinkGeneric 08/2022
1	Imipenem Drug Combination Cilastatin (Primaxin)FDA Link 08/2022
1	Carbapenems (Carbapenem Antibiotics)IBA 08/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 08/2022
1	2019-nCoV Vaccine mRNA-1273IBA 01/2022

Therapy/Procedure

46	Therapeutics 06/2022 - 01/2008
20	Stem Cell Transplantation 08/2022 - 12/2010
11	Drug Therapy (Chemotherapy) 08/2022 - 09/2005
3	Aftercare (After-Treatment) 01/2022 - 03/2011
3	Radiotherapy 01/2021 - 01/2016
3	Duration of Therapy 12/2020 - 03/2014
2	Precision Medicine 01/2021 - 01/2020
2	Transplantation 12/2020 - 01/2013
2	Erythrocyte Transfusion 12/2017 - 01/2017